Second-site NMR screening and linker design

被引:47
作者
Jahnke, W [1 ]
Flörsheimer, A
Blommers, MJJ
Paris, CG
Heim, J
Nalin, CM
Perez, LB
机构
[1] Novartis Pharma AG, Cent Technol, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Oncol Res, CH-4002 Basel, Switzerland
[3] Novartis Pharma AG, Cent Technol, Summit, NJ 07901 USA
[4] Novartis Pharma AG, Oncol Res, Summit, NJ 07901 USA
关键词
D O I
10.2174/1568026033392778
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
One of the prime merits of NMR as a tool for lead finding in drug discovery research is its sensitivity and robustness to detect weak protein-ligand interactions. This sensitivity allows to build up ligands for a given target in a modular way, by a fragment-based approach. In this approach, two ligands are seperately identified which bind to the target protein generally weakly but at adjacent binding sites. In a next step, they are chemically linked to produce a high-affinity ligand. This review discusses methods to detect "second-site" ligands that bind to a protein in the presence of a "first-site" ligand, and methods to elucidate structural details on the spatial orientation of both ligands, so that chemical linkage is based on a large piece of experimental information. Published examples from second-site screening and linker design are summarized, and are complemented by previously unpublished in-house examples.
引用
收藏
页码:69 / 80
页数:12
相关论文
共 50 条
[21]   Inhibition of prostate cancer cell growth by second-site androgen receptor antagonists [J].
Joseph, James D. ;
Wittmann, Bryan M. ;
Dwyer, Mary A. ;
Cui, Huaxia ;
Dye, Delita A. ;
McDonnell, Donald P. ;
Norris, John D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (29) :12178-12183
[22]   Second-site eversion of a structural defect in bacteriophage T4 lysozyme [J].
Bouvier, SE ;
Poteete, AR .
FASEB JOURNAL, 1996, 10 (01) :159-163
[23]   SECOND-SITE IDH2 MUTATIONS CONFER RESISTANCE TO ENASIDENIB IN TRANS [J].
不详 .
CANCER DISCOVERY, 2018, 8 (08) :913-913
[24]   A second-site suppressor strategy for chemical genetic analysis of diverse protein kinases [J].
Zhang C. ;
Kenski D.M. ;
Paulson J.L. ;
Bonshtien A. ;
Sessa G. ;
Cross J.V. ;
Templeton D.J. ;
Shokat K.M. .
Nature Methods, 2005, 2 (6) :435-441
[25]   Discovery of a novel second-site corrector for delF508 CFTR mutations [J].
Lam, Philip ;
Boss, Kelly ;
Cheung, Atwood ;
Epple, Robert ;
Espinola, Sheryll ;
Honda, Ayako ;
Lay, Cecilia ;
Li, Wei ;
Malik, Hasnain ;
Whitehead, Lewis ;
Wu, Baogen ;
Barnes, William ;
Patel, Sejal .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
[26]   Putative interhelical interactions within the PheP protein revealed by second-site suppressor analysis [J].
Dogovski, C ;
Pi, J ;
Pittard, AJ .
JOURNAL OF BACTERIOLOGY, 2003, 185 (21) :6225-6232
[27]   Targeted gene replacement by homologous recombination in Drosophila stimulates production of second-site mutations [J].
Roy, Swarnava ;
Hart, Craig M. .
FLY, 2010, 4 (01) :12-17
[28]   Understanding chloroplast biogenesis using second-site suppressors of immutans and var2 [J].
Putarjunan, Aarthi ;
Liu, Xiayan ;
Nolan, Trevor ;
Yu, Fei ;
Rodermel, Steve .
PHOTOSYNTHESIS RESEARCH, 2013, 116 (2-3) :437-453
[29]   Second-site suppressors of Rous sarcoma virus CA mutations: Evidence for interdomain interactions [J].
Bowzard, JB ;
Wills, JW ;
Craven, RC .
JOURNAL OF VIROLOGY, 2001, 75 (15) :6850-6856
[30]   Understanding chloroplast biogenesis using second-site suppressors of immutans and var2 [J].
Aarthi Putarjunan ;
Xiayan Liu ;
Trevor Nolan ;
Fei Yu ;
Steve Rodermel .
Photosynthesis Research, 2013, 116 :437-453